发明申请
US20060165679A1 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 2 (vpac2)
审中-公开
与血管活性肠肽受体2（vpac2）相关的疾病的诊断和治疗
- 专利标题： Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 2 (vpac2)
- 专利标题（中）： 与血管活性肠肽受体2（vpac2）相关的疾病的诊断和治疗
-
申请号： US10513867申请日： 2003-04-25
-
公开(公告)号： US20060165679A1公开(公告)日： 2006-07-27
- 发明人: Stefan Golz , Ulf Bruggemeier , Holger Summer
- 申请人： Stefan Golz , Ulf Bruggemeier , Holger Summer
- 申请人地址： DE Leverkusen 51368
- 专利权人： Bayer HealthCare AG
- 当前专利权人： Bayer HealthCare AG
- 当前专利权人地址： DE Leverkusen 51368
- 优先权： EP02010111.9 20020508
- 国际申请： PCT/EP03/04303 WO 20030425
- 主分类号： G01N33/567
- IPC分类号： G01N33/567 ; A61K39/395 ; A61K48/00 ; A61K38/17
摘要：
The invention provides a human VPAC2 which is associated with the disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, genitourinary diseases, inflammation. The invention also provides assays for the identification of compounds useful in the treatment or prevention of disorders of the peripheral and central nervous system, cardio-vascular diseases, hematological diseases, genitourinary diseases, inflammation. The invention also features compounds which bind to and/or activate or inhibit the activity of VPAC2 as well as pharmaceutical compositions comprising such compounds.